TY - JOUR
T1 - Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS)
AU - Bushnell, C. D.
AU - Newby, L. K.
AU - Goldstein, L. B.
AU - Lin, F.
AU - Yaffe, K.
AU - Simon, J. A.
PY - 2004/3/23
Y1 - 2004/3/23
N2 - The authors investigated the relationship between statin use and the risk of stroke in the Heart and Estrogen-Progestin Replacement Study (HERS). Despite large reductions in relative risk point estimates, statin use was not associated with differences in the risks of all fatal stroke (relative hazard [RH] 0.52, 95% CI 0.23 to 1.18, p = 0.12), fatal ischemic stroke (RH 0.51, 95% CI 0.18 to 1.45, p = 0.21), fatal hemorrhagic stroke (RH 0.18, 95% CI 0.02 to 1.46, p = 0.11), or TIA (RH 1.32, 95% CI 0.84 to 2.09, p = 0.23).
AB - The authors investigated the relationship between statin use and the risk of stroke in the Heart and Estrogen-Progestin Replacement Study (HERS). Despite large reductions in relative risk point estimates, statin use was not associated with differences in the risks of all fatal stroke (relative hazard [RH] 0.52, 95% CI 0.23 to 1.18, p = 0.12), fatal ischemic stroke (RH 0.51, 95% CI 0.18 to 1.45, p = 0.21), fatal hemorrhagic stroke (RH 0.18, 95% CI 0.02 to 1.46, p = 0.11), or TIA (RH 1.32, 95% CI 0.84 to 2.09, p = 0.23).
UR - http://www.scopus.com/inward/record.url?scp=1842614342&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1842614342&partnerID=8YFLogxK
U2 - 10.1212/01.WNL.0000115171.46508.19
DO - 10.1212/01.WNL.0000115171.46508.19
M3 - Article
C2 - 15037702
AN - SCOPUS:1842614342
SN - 0028-3878
VL - 62
SP - 968
EP - 970
JO - Neurology
JF - Neurology
IS - 6
ER -